Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease

Abstract

Background:Prolonged use of parenteral nutrition (PN) in neonates can lead to parenteral nutrition-associated liver disease (PNALD), manifested by elevated direct bilirubin concentrations, and in some cases progressing to hepatic failure. When new potential means of preventing PNALD in the neonatal intensive care unit (NICU), such as Omegaven usage, are… (More)
DOI: 10.1038/sj.jp.7211686

6 Figures and Tables

Topics

  • Presentations referencing similar topics